We did not find any significant difference in levels of NICD expression in colon cancer cells with different treatments; however, the levels of RBP-jκ and Hes1 proteins were reduced in SW480-shLEF1 cells and SW620-shLEF1 cells compared with control cells (Figure 6A). Here, HES1 is linked to malignant colon neoplasm.